Things aren't all that bleak for BPUR, apparently the regulators like the color choice for the bottles although a few other issues remain..."toxicology, quality, clinical efficacy and safety,......." Did they miss any?
In a hurry to approve Hemopure?.... I would say no also.
Market Data 
Markets 
AI
